BR112022017008A2 - Compostos para uso no tratamento de infecção por coronavírus - Google Patents
Compostos para uso no tratamento de infecção por coronavírusInfo
- Publication number
- BR112022017008A2 BR112022017008A2 BR112022017008A BR112022017008A BR112022017008A2 BR 112022017008 A2 BR112022017008 A2 BR 112022017008A2 BR 112022017008 A BR112022017008 A BR 112022017008A BR 112022017008 A BR112022017008 A BR 112022017008A BR 112022017008 A2 BR112022017008 A2 BR 112022017008A2
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- compounds
- virus infection
- corona virus
- infection
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20382152 | 2020-03-02 | ||
| EP20382192 | 2020-03-13 | ||
| EP20382266 | 2020-04-02 | ||
| EP20382339 | 2020-04-27 | ||
| EP20382815 | 2020-09-16 | ||
| EP20382816 | 2020-09-16 | ||
| PCT/EP2021/055137 WO2021175826A1 (en) | 2020-03-02 | 2021-03-02 | Compounds for use in the treatment of coronavirus infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022017008A2 true BR112022017008A2 (pt) | 2022-10-11 |
Family
ID=74797953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022017008A BR112022017008A2 (pt) | 2020-03-02 | 2021-03-02 | Compostos para uso no tratamento de infecção por coronavírus |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20230158102A1 (https=) |
| EP (1) | EP4114436A1 (https=) |
| JP (1) | JP2023517295A (https=) |
| KR (1) | KR20220151181A (https=) |
| CN (1) | CN115666615A (https=) |
| AU (1) | AU2021232534A1 (https=) |
| BR (1) | BR112022017008A2 (https=) |
| CA (1) | CA3169791A1 (https=) |
| CL (1) | CL2022002398A1 (https=) |
| CO (1) | CO2022014115A2 (https=) |
| IL (1) | IL296066A (https=) |
| MX (1) | MX2022010922A (https=) |
| PE (1) | PE20231069A1 (https=) |
| PY (1) | PY2117315A (https=) |
| TW (1) | TW202144380A (https=) |
| UY (1) | UY39108A (https=) |
| WO (1) | WO2021175826A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021231521A1 (en) * | 2020-03-02 | 2022-10-06 | Pharma Mar, S.A. | PLD for use in combination in the treatment of coronavirus |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8922026D0 (en) * | 1989-09-29 | 1989-11-15 | Pharma Mar Sa | Novel anti-viral and cytotoxic agent |
| GB9803448D0 (en) | 1998-02-18 | 1998-04-15 | Pharma Mar Sa | Pharmaceutical formulation |
| CA2405779A1 (en) | 2000-04-07 | 2001-10-18 | The Trustees Of The University Of Pennsylvania | Tamandarin and didemnin analogs and methods of making and using them |
| UA76718C2 (uk) | 2000-06-30 | 2006-09-15 | Фарма Мар, С.А. | Протипухлинні похідні аплідину |
| JP2006523214A (ja) | 2003-03-21 | 2006-10-12 | ジユーリー，マデレーン・エム | タマンダリン類似物およびこれらのフラグメントそして製造方法および使用方法 |
| US7605135B2 (en) * | 2003-11-10 | 2009-10-20 | The University Of Hong Kong | Baicalin as a treatment for SARS infection |
| JP2012512839A (ja) * | 2008-12-19 | 2012-06-07 | ファルマ、マール、ソシエダード、アノニマ | 抗腫瘍性化合物 |
| WO2011020913A2 (en) | 2009-08-21 | 2011-02-24 | Pharma Mar, S.A. | Cyclodepsipeptide antiviral compounds |
| CN115461067A (zh) * | 2020-03-02 | 2022-12-09 | 法马马有限公司 | 用于炎症的化合物 |
-
2021
- 2021-03-02 US US17/908,524 patent/US20230158102A1/en active Pending
- 2021-03-02 CA CA3169791A patent/CA3169791A1/en active Pending
- 2021-03-02 TW TW110107291A patent/TW202144380A/zh unknown
- 2021-03-02 CN CN202180018709.2A patent/CN115666615A/zh active Pending
- 2021-03-02 KR KR1020227034222A patent/KR20220151181A/ko active Pending
- 2021-03-02 PE PE2022001871A patent/PE20231069A1/es unknown
- 2021-03-02 JP JP2022552932A patent/JP2023517295A/ja active Pending
- 2021-03-02 BR BR112022017008A patent/BR112022017008A2/pt unknown
- 2021-03-02 AU AU2021232534A patent/AU2021232534A1/en active Pending
- 2021-03-02 WO PCT/EP2021/055137 patent/WO2021175826A1/en not_active Ceased
- 2021-03-02 UY UY0001039108A patent/UY39108A/es unknown
- 2021-03-02 PY PY202102117315A patent/PY2117315A/es unknown
- 2021-03-02 MX MX2022010922A patent/MX2022010922A/es unknown
- 2021-03-02 IL IL296066A patent/IL296066A/en unknown
- 2021-03-02 EP EP21708649.5A patent/EP4114436A1/en active Pending
-
2022
- 2022-09-02 CL CL2022002398A patent/CL2022002398A1/es unknown
- 2022-09-30 CO CONC2022/0014115A patent/CO2022014115A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20220151181A (ko) | 2022-11-14 |
| UY39108A (es) | 2021-09-30 |
| JP2023517295A (ja) | 2023-04-25 |
| CN115666615A (zh) | 2023-01-31 |
| PY2117315A (es) | 2022-05-10 |
| MX2022010922A (es) | 2022-09-29 |
| PE20231069A1 (es) | 2023-07-17 |
| AU2021232534A1 (en) | 2022-10-06 |
| TW202144380A (zh) | 2021-12-01 |
| US20230158102A1 (en) | 2023-05-25 |
| CO2022014115A2 (es) | 2022-11-18 |
| IL296066A (en) | 2022-11-01 |
| CL2022002398A1 (es) | 2023-06-30 |
| EP4114436A1 (en) | 2023-01-11 |
| CA3169791A1 (en) | 2021-09-10 |
| WO2021175826A1 (en) | 2021-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112022026321A2 (pt) | Análogos de 1'-ciano nucleosídeo e usos dos mesmos | |
| LT3953330T (lt) | Nitrilo turintys junginiai, naudingi kaip antivirusiniai agentai, skirti koronavirusinei infekcijai gydyti | |
| BR112022000503A2 (pt) | Compostos úteis para tratar infecções por vírus influenza | |
| BR112023002951A2 (pt) | Compostos de fosfolipídio e usos destes | |
| BR112023025358A2 (pt) | Inibidores de protease como antivirais | |
| BR112022021962A2 (pt) | Imidazopiridazinas como moduladores de il-17 | |
| BR112021022624A2 (pt) | Compostos para o tratamento da doença de huntington | |
| BRPI0720569B8 (pt) | compostos de tetraciclina substituída e uso dos ditos compostos para o tratamento de uma infecção bacteriana, viral ou parasitária | |
| BR112018005048B8 (pt) | uso de um composto antiviral ou sal do mesmo para o tratamento de uma infecção por coronaviridae | |
| HN2003000348A (es) | Compuestos de benzofurano, composiciones y metodos para tratamiento y profilaxis de infeccion virales de hepatitis c y enfermedades asociadas. | |
| BRPI0819328A8 (pt) | Compostos inibidores de replicação de vírus da imunodeficiência humana, composição farmacêutica e uso dos ditos compostos | |
| BRPI0402394A (pt) | Composições para tratamento do cabelo e composições para pós-tratamento do cabelo destinadas à proteção contra danos provocados por tratamento quìmico e à reparação de cabelo já danificado, compreendendo como substâncias ativas compostos alquilguanidina | |
| BR112018014794A2 (pt) | pirimidinas substituídas com arila para uso em infecção pelo vírus influenza | |
| BRPI0408353A (pt) | composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto | |
| MX2022012575A (es) | Compuestos para usarse para tratar la enfermedad de huntington. | |
| MX2022011173A (es) | Tratamiento de infeccion por coronavirus. | |
| BR112013024974A2 (pt) | composto, composição farmacêutica, método para o tratamento de infecções virais, e, processo para preparar um composto | |
| BRPI1012666B8 (pt) | cocristal de etravirina e nicotinamida, composição farmacêutica, combinação compreendendo o mesmo, seu processo para a preparação e uso | |
| ECSP10010602A (es) | Compuestos de anillo fusionados y uso de los mismos | |
| UY39313A (es) | Composiciones amortiguadoras para el tratamiento de infecciones virales transmitidas por el aire | |
| BR112018015629A2 (pt) | ?composto, composição, método para tratar um mamífero infectado com o vírus hiv, e, proteína mutante tripla? | |
| EA202193223A1 (ru) | Другие гетероароматические соединения, действующие против рсв | |
| BR112022016653A2 (pt) | Pld para uso em combinação no tratamento de coronavírus | |
| BR112023018655A2 (pt) | Compostos antibacterianos | |
| BR112022017008A2 (pt) | Compostos para uso no tratamento de infecção por coronavírus |